To determine the sensitivity of HDAC inhibitors in SCC cells, we screened a panel of 10 lung SCC cells and three normal fibroblast cells against belinostat to determine the half‐maximum inhibitory concentrations (IC50). The gene discussed is HDAC9; the disease is medical procedure.